Aashirya Drugs Private Limited - Company Profile

It is a pharma private limited company based in Gorakhpur, Uttar Pradesh, India, established in 2018.
2018 Gorakhpur, Uttar Pradesh, India Active
Last Updated:
Access Report
About Aashirya Drugs Private Limited

Aashirya Drugs Private Limited, a active private limited company, was established on 16 February 2018 in Gorakhpur, Uttar Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24299UP2018PTC101026. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.70 M.

Its leadership includes Shubhanshu Kumar Shah (Director), Prabha Devi (Additional Director). Past directors included Amit Kumar Mishra. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at C/O Sunil Agarwal, Mahewa Mahewa Rustampur, Gorakhpur, Uttar Pradesh, 273001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24299UP2018PTC101026

  • Registration Number

    101026

  • Incorporation Date

    16 February 2018

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.70 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.70 M
  • Company Age 8 Year, 2 Days
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** %
  • Profit Growth **** 95.81%
  • Ebitda **** 97.08%
  • Net Worth -3.09%
  • Total Assets -3.23%
Company report

Aashirya Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Aashirya Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Aashirya Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Shubhanshu Kumar Shah Director 16 Feb 2018 Current
Prabha Devi Additional Director 18 Aug 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 19 Aug 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aashirya Drugs.

Aashirya Drugs Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 95.81% increase in profit. The company's net worth dipped by a decrease of 3.09%.

Aashirya Drugs revenue growth over time
Aashirya Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -3.23%
*******
*******
*******
*******
Profit or Loss
*******
 95.81%
*******
*******
*******
*******
Net Worth
*******
 -3.09%
*******
*******
*******
*******
EBITDA
*******
 97.08%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aashirya Drugs?

Unlock access to Aashirya Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Aashirya Drugs?

Unlock and access historical data on people associated with Aashirya Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aashirya Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aashirya Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aashirya Drugs
Recent Activity within the Organization
  • Annual General Meeting

    The activity Aashirya Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Director Appointment

    The activity Prabha Devi was appointed as a Additional Director was appointed as a Additional Director on 18 Aug 2025 & has been associated with this company since 6 months 3 days . was completed.

  • Balance Sheet

    The activity Aashirya Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was completed.

  • Director Appointment

    Shubhanshu Kumar Shah was appointed as a Director was appointed as a Director on 16 Feb 2018 & has been associated with this company since 8 years 2 days . was recorded as a recent event.

  • Company Incorporation

    Progress on Aashirya Drugs Private Limited was registered on 16 Feb 2018 with Roc Kanpur & aged 8 years 2 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Aashirya Drugs Private Limited?

The CIN of Aashirya Drugs Private Limited is U24299UP2018PTC101026.

Where is Aashirya Drugs Private Limited headquartered?

Aashirya Drugs Private Limited is headquartered at C/O Sunil Agarwal, Mahewa Mahewa Rustampur, Gorakhpur, Uttar Pradesh, 273001.

When was Aashirya Drugs Private Limited incorporated?

Aashirya Drugs Private Limited was incorporated on 16 February 2018.

Who are the current directors of Aashirya Drugs Private Limited?

The current directors of Aashirya Drugs Private Limited are

What is the primary industry of Aashirya Drugs Private Limited?

The primary industry of Aashirya Drugs Private Limited is Pharma.

Is Aashirya Drugs Private Limited a listed company?

Aashirya Drugs Private Limited is unlisted.

What is the capital structure of Aashirya Drugs Private Limited?

The authorized capital of Aashirya Drugs Private Limited is ₹1.00 M, and the paid-up capital is ₹0.70 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available